Add BrightSurf on Google Email

Brigham and Women's Hospital


How low should LDL cholesterol go?

Researchers found that ultra-low LDL cholesterol levels (below 10 mg/dL) significantly reduced cardiovascular event risk by over 40%. No adverse effects on cognition or safety endpoints were reported. The study suggests achieving low LDL cholesterol levels beyond current treatment targets may further reduce cardiovascular risk.

SourceBrigham and Women's Hospital·JournalThe Lancet·DateAug 28, 2017

When two is better than three: Dual antithrombotic therapy cuts bleeding risk

A new study found that using two anticlotting medicines instead of three can reduce the risk of major bleeding in patients with atrial fibrillation who have had a stent placed. The RE-DUAL PCI trial showed that dabigatran, combined with either clopidogrel or ticagrelor, cut the risk of bleeding by half compared to standard triple therapy.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateAug 27, 2017

Additional studies needed to evaluate CVD risks of hormone therapy for transgender patients

New narrative review calls for additional research to better understand cardiovascular disease (CVD) and risk factors in transgender individuals receiving long-term cross-sex hormone therapy. Studies suggest worsening cardiovascular risk factors in transgender men and increased thromboembolic risk in transgender women.

SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·DateJul 24, 2017

Cyber attacks can threaten public health

A recent study highlights the growing threat of cyber attacks on information systems, with 64% of organizations reporting successful medical file targeted attacks in 2016. The authors stress the need to acknowledge public health implications of information security to improve dialogue and protect patient care.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateJul 12, 2017

Neurons that regenerate, neurons that die

A new study found that a specific transcription factor can help certain neurons regenerate, but simultaneously kill others, in the optic nerve. This discovery may lead to new treatment strategies for restoring vision or repairing injury by regenerating functional connections and considering combination therapies.

SourceBrigham and Women's Hospital·JournalNeuron·DateJun 21, 2017

Understanding HIV's persistence

A new study found that HIV-1 infected cells can persist in the body for decades by exploiting normal cell proliferation. The research identified a single infected CD4 T cell that can amplify the number of virally infected cells through clonal proliferation, leading to a million-fold increase.

SourceBrigham and Women's Hospital·JournalJournal of Clinical Investigation·DateJun 19, 2017

Why we get diarrhea

A new study published in Cell Host and Microbe has uncovered the immune mechanism driving diarrhea and its role in pathogen clearance. Researchers found that diarrhea resulting from the signaling of specific molecules helps promote pathogen clearance and limit disease severity.

SourceBrigham and Women's Hospital·JournalCell Host & Microbe·DateJun 14, 2017

Building a better blood-brain barrier model

Researchers at Brigham and Women's Hospital have developed a new model to mimic the blood-brain barrier, using miniature spheroids that replicate key properties and functions. This innovative approach may advance neuroscience research and expedite the discovery of brain-penetrant drugs for treating diseases.

SourceBrigham and Women's Hospital·JournalNature Communications·DateJun 6, 2017

Study offers hard data on food allergies

A new study published in the Journal of Allergy and Clinical Immunology found that 3.6 percent of the population studied had a documented food allergy or intolerance. Shellfish was the most commonly reported food allergy, with the highest rates among females and Asians.

SourceBrigham and Women's Hospital·JournalJournal of Allergy and Clinical Immunology·DateMay 31, 2017

Racial disparities in risk of stroke

Researchers found that black patients have not benefited equally from declining risk factors for stroke, with a greater decline in hypertension. Despite decreasing contributions of major risk factors across the entire participant sample, the disparity in reducing these risks highlights racial disparities in cardiovascular health.

SourceBrigham and Women's Hospital·JournalNew England Journal of Medicine·DateMay 24, 2017

Opioid use before knee replacement surgery results in worse pain outcomes for patients

A recent study published in the Journal of Bone and Joint Surgery found that preoperative opioid use is associated with less pain reduction after total knee replacement surgery. Patients who used opioids before their procedure experienced about 9 percent less pain relief at six months following surgery compared to those who did not.

SourceBrigham and Women's Hospital·JournalJournal of Bone and Joint Surgery·DateMay 18, 2017

A path toward ending AIDS in the US by 2025

A new study models HIV incidence, prevalence, and mortality to determine feasible targets for ending the US AIDS epidemic. Achieving a reduction of 12,000 new infections by 2025 could mark an important turning point in the epidemic, with significant declines in HIV transmission rates and related deaths.

SourceBrigham and Women's Hospital·JournalAmerican Journal of Preventive Medicine·DateMay 15, 2017